Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?

Santos C Sieiro, Fernández X Casas, Morales C Moriano, Alvarez E Diez, Álvarez C Castro, López A Robles, Sandoval T Perez
doi: https://doi.org/10.1101/2020.09.01.20184333

Article usage

Article usage: September 2020 to July 2025

AbstractFullPdf
Sep 20205180130
Oct 2020125053
Nov 2020127074
Dec 202082047
Jan 2021209056
Feb 2021262041
Mar 202192325
Apr 202194314
May 20217438
Jun 20215108
Jul 202148319
Aug 202144515
Sep 202148415
Oct 202147124
Nov 202140219
Dec 20212806
Jan 202227510
Feb 20221312
Mar 20222113
Apr 20222405
May 2022108110
Jun 20223028
Jul 20221201
Aug 20222113
Sep 202233311
Oct 20222506
Nov 20221803
Dec 20222117
Jan 20231903
Feb 20231337
Mar 20231312
Apr 20231915
May 2023918
Jun 2023966
Jul 2023504
Aug 2023171310
Sep 20231244
Oct 20231203
Nov 2023903
Dec 20231313
Jan 2024403
Feb 20241636
Mar 20241418
Apr 2024738
May 20241524
Jun 2024832
Jul 2024808
Aug 2024824
Sep 20241815
Oct 2024752
Nov 20241208
Dec 2024713
Jan 20251615
Feb 2025996
Mar 202521206
Apr 20251566
May 20251849
Jun 202581106
Jul 2025121313
Back to top
Posted September 03, 2020.
Download PDF
Data/Code
Email
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?
Santos C Sieiro, Fernández X Casas, Morales C Moriano, Alvarez E Diez, Álvarez C Castro, López A Robles, Sandoval T Perez
medRxiv 2020.09.01.20184333; doi: https://doi.org/10.1101/2020.09.01.20184333
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area